SonoSite
This article was originally published in The Gray Sheet
Executive Summary
Nets approximately $30.9 mil. from secondary offering of 2.6 mil. shares of common stock at $13 per share. The developer of miniaturized, high-performance, digital ultrasound imaging devices recieved 510(k) clearance in March to market the commercial version of its hand-carried, all-digital ultrasound device. Proceeds will be used primarily for operating expenses, including product development, sales and marketing costs. Underwriters Vector Securities International and Prudential Securities hold an over-allotment option of 390,000 additional shares